| | Author (year) | Country | Design | Setting | Total patient (n) | Age, mean (SD or range) | Male | Etiology (n) | Reason for failed ERCP (n) | Stent diameter | CBD diameter (mm) | Median follow-up (day) |
| | Jacques et al. (2020), [26] | France | Prospective | Multicenter | 70 | 75 (61–92) | 38 | Pancreatic cancer (54),
Cholangiocarcinoma (3),
Ampullary cancer (4),
Duodenal cancer (2),
Others (7) | Duodenal stenosis (31),
Tumoral involvement of papilla (15),
Cannulation failure (17),
Other (1) | 6 mm (60),
8 mm (9),
10 mm (1) | 17.7 ± 5 | 153 | | Jacques et al. (2019), [27] | France | Retrospective | Multicenter | 52 | 78 (61–92) | 24 | Pancreatic cancer (43),
Cholangiocarcinoma (2),
Duodenal lymphoma (1),
Duodenal cancer (2),
Degenerated IPMN (2),
Peritoneal carcinomatosis (1),
Stones (1) | Duodenal stenosis (18),
Tumoral involvement of papilla (10),
Cannulation failure (14),
Prior duodenal stent (9),
Other (1) | 6 mm (43),
8 mm (7),
15 mm (2) | 17.2 (9–25) | 157 | | El Chafic et al. (2019), [25] | USA | Retrospective | Multi-center | 67 | 68.8 ± 11.8 | 21 | Peri-ampullary cancer (56)
Metastatic cancer (11) | Duodenal stenosis (28),
Tumoral involvement of papilla (28),
Cannulation failure (9) | 10 mm (67) | 17.6 ± 3.6 | 119# | | Tsuchiya et al. (2018), [28] | Asia | Prospective | Multicenter | 19 | 70.6 ± 13.9 | 12 | Pancreatic cancer (10),
Cholangiocarcinoma (2),
Ampullary cancer (1),
Duodenal cancer (1),
Metastatic cancer (4),
Sarcoma (1) | Duodenal stenosis (4),
Cannulation failure (15) | 6 mm (10),
8 mm (9) | 17.3 ± 5.5 | 145 | | Anderloni et al. (2019), [23] | Italy | Retrospective | Single-center | 46 | 73.1 ± 12.6 | 24 | Pancreatic cancer (40),
Cholangiocarcinoma (1),
Ampullary cancer (2),
Duodenal cancer (3) | Duodenal stenosis (9),
Tumoral involvement of papilla (19),
Cannulation failure (12),
Prior duodenal stent (6) | 6 mm (21),
8 mm (19),
10 mm (6) | 17.26 ± 3.34 | 83 | | Anderloni et al. (2018), [24] | Italy | Retrospective | Single-center | 16 | 69.9 ± 13.3 | 8 | NA | NA | 6 mm (9),
8 mm (4),
10 mm (3) | NA | 138.7 |
|
|
CBD, Common bile duct; IPMN, intraductal papillary mucinous neoplasm; ERCP, endoscopic retrograde cholangiopancreatography; NA, not available; #20 patients were lost follow-up.
|
